文献速递小儿神经外科与脑积水神经重症

特发性正常压力脑积水的北京协和医院评估体系与临床实践

The PUMCH Evaluation System of Idiopathic Normal Pressure Hydrocephalus and Clinical Practice.
PubMed 文献 · World Neurosurg · 2022-11-10

该研究回顾性分析2019年10月至2022年2月在北京协和医院接受脑室腹腔分流术的20例术前腰穿放液试验阳性的特发性正常压力脑积水患者,90%的患者在临床三联征中至少1项改善,提示该院评估流程具有预测价值;高血压、糖尿病及脑供血不足等基础疾病与特发性正常压力脑积水发病相关。

要点

  • 该院腰穿放液试验流程对分流术后改善具有预测价值,20例中90%至少1项三联征改善。
  • 高血压、糖尿病及脑供血不足等基础疾病与特发性正常压力脑积水发病相关。
  • 作者认为该评估体系是特发性正常压力脑积水评估的有效工具,可指导临床决策。

核心结论

  • 作者认为该院评估体系是特发性正常压力脑积水评估的有效工具,可指导临床决策。
  • 作者认为基础疾病应纳入考虑,因其参与特发性正常压力脑积水的发病与进展。
  • 作者认为更好识别潜在特发性正常压力脑积水患者将减轻家庭和老龄化社会的负担。

研究设计与样本

  • 回顾性分析2019年10月至2022年2月在北京协和医院术前腰穿放液试验阳性并接受脑室腹腔分流术的20例特发性正常压力脑积水患者的数据。
  • 分析术前与术后表现数据,并考虑任何基础疾病病史。
  • 同期腰穿放液试验阴性的患者也被随访。

主要发现

  • 2019年10月至2022年2月对20例正常压力脑积水患者实施脑室腹腔分流术。
  • 20例中90%在临床三联征中至少1项改善,证明北京协和医院试验流程的预测能力。
  • 高血压、糖尿病及脑供血不足等基础疾病被发现与正常压力脑积水发病相关。

临床怎么用

  • 作者认为该评估体系是特发性正常压力脑积水评估的有效工具,可指导临床决策。
  • 作者认为基础疾病应纳入考虑,因其参与特发性正常压力脑积水的发病与进展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Differentiating idiopathic normal pressure hydrocephalus (iNPH) from other neurodegenerative diseases is challenging. Only a portion of the patients clinically suspected of iNPH would respond to surgical intervention. A cerebrospinal fluid (CSF) tap test is usually used to predict surgery outcomes and hence aid clinical decision-making, but the workup varies. We introduce the CSF tap test conducted at our center and examine its power by analyzing data from a series of iNPH cases that underwent shunt placement. We analyze common features in the past medical history of our patients and investigate whether they are related to the etiology of iNPH. METHODS: Data from 20 patients who were positive in the tap tests preoperatively and received ventriculoperitoneal shunting (VPS) were retrospectively analyzed. Preoperative and postoperative performance data were analyzed. History of any underlying medical conditions was taken into consideration. Patients with negative tap test results of the same period were also followed up. RESULTS: We performed VPS placement in 20 NPH patients from October 2019 to February 2022. Of these, 90% exhibited improvement in at least 1 of the clinical triad, proving the predictive power of the Peking Union Medical College Hospital test workflow. The underlying conditions like hypertension, diabetes and insufficiency in cerebral blood supply were also found to be associated with the onset of NPH. CONCLUSION: Our evaluation system is a valid tool for NPH assessment and can guide clinical decision-making. Comorbidities should be taken into consideration as they contribute to the pathogenesis and progression of NPH. Better identification of potential iNPH patients will lower the burden exerted on the family and the aging society.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yin R, Chang J, Zhang X, et al. The PUMCH Evaluation System of Idiopathic Normal Pressure Hydrocephalus and Clinical Practice. World Neurosurg. 2022. PMID: 36371044. doi:10.1016/j.wneu.2022.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。